Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Statistics

Total Valuation

VRDN has a market cap or net worth of $1.07 billion. The enterprise value is $456.96 million.

Market Cap	1.07B
Enterprise Value	456.96M

Important Dates

The last earnings date was Tuesday, May 6, 2025, before market open.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

VRDN has 81.59 million shares outstanding. The number of shares has increased by 47.46% in one year.

Current Share Class	81.59M
Shares Outstanding	81.59M
Shares Change (YoY)	+47.46%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	104.37%
Float	72.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3,544.66
Forward PS	40.32
PB Ratio	2.58
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1,513.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.49, with a Debt / Equity ratio of 0.04.

Current Ratio	19.49
Quick Ratio	18.88
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-110.67

Financial Efficiency

Return on equity (ROE) is -51.95% and return on invested capital (ROIC) is -34.19%.

Return on Equity (ROE)	-51.95%
Return on Assets (ROA)	-32.62%
Return on Invested Capital (ROIC)	-34.19%
Return on Capital Employed (ROCE)	-53.73%
Revenue Per Employee	$2,112
Profits Per Employee	-$1.70M
Employee Count	143
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.61% in the last 52 weeks. The beta is 0.62, so VRDN's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-5.61%
50-Day Moving Average	13.84
200-Day Moving Average	17.98
Relative Strength Index (RSI)	49.13
Average Volume (20 Days)	891,451

Short Selling Information

The latest short interest is 10.12 million, so 12.41% of the outstanding shares have been sold short.

Short Interest	10.12M
Short Previous Month	11.04M
Short % of Shares Out	12.41%
Short % of Float	13.92%
Short Ratio (days to cover)	10.63

Income Statement

In the last 12 months, VRDN had revenue of $302,000 and -$243.10 million in losses. Loss per share was -$3.33.

Revenue	302,000
Gross Profit	-237.02M
Operating Income	-337.00M
Pretax Income	-228.06M
Net Income	-243.10M
EBITDA	-336.49M
EBIT	-337.00M
Loss Per Share	-$3.33

Balance Sheet

The company has $636.63 million in cash and $23.11 million in debt, giving a net cash position of $613.53 million or $7.52 per share.

Cash & Cash Equivalents	636.63M
Total Debt	23.11M
Net Cash	613.53M
Net Cash Per Share	$7.52
Equity (Book Value)	604.47M
Book Value Per Share	5.09
Working Capital	623.51M

Cash Flow

In the last 12 months, operating cash flow was -$279.75 million and capital expenditures -$597,000, giving a free cash flow of -$280.35 million.

Operating Cash Flow	-279.75M
Capital Expenditures	-597,000
Free Cash Flow	-280.35M
FCF Per Share	-$3.44

Margins

Gross Margin	n/a
Operating Margin	-111,590.73%
Pretax Margin	-102,092.38%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VRDN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.46%
Shareholder Yield	-47.46%
Earnings Yield	-22.71%
FCF Yield	-26.19%

Analyst Forecast

The average price target for VRDN is $36.82, which is 180.64% higher than the current price. The consensus rating is "Buy".

Price Target	$36.82
Price Target Difference	180.64%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	409.61%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 13, 2020. It was a reverse split with a ratio of 0.0666666:1.

Last Split Date	Nov 13, 2020
Split Type	Reverse
Split Ratio	0.0666666:1

Scores

VRDN has an Altman Z-Score of 10.51.

Altman Z-Score	10.51
Piotroski F-Score	n/a